NEW YORK (GenomeWeb News) — GeneGo said yesterday that Aveo Pharmaceuticals has licensed its MetaCore 4.5 data-mining suite.
 
The latest version of the suite has disease enrichment and functional ontology functions, and is used to help target, select, and validate biomarkers.
 
The suite, which can concurrently visualize gene expression, proteomics, genetic, and metabolic data, has a management system that can be used to upload and handle thousands of genome-wide files, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.